Ritu Thamman MD Mamas A. Mamas Dr. Martha Gulati ♥️🫀❤️‍🩹🇨🇦 Omar Khalique Roosha Parikh Mohammed Chamsi Pasha, FACC, FASE Leandro Slipczuk Khurram Nasir Nidhi Madan, MD, MPH Viet Le DMSc PA-C FACC FAHA HF-Cert Juan Lopez-Mattei, MD Manish Motwani SABOURETCardiologist Dr Anastasia Mihailidou FAHA FCSANZ FESC Justine VarieurTurco Radhika Rajgopal Singh Chittur Sivaram Dr G Rajesh (Gopalan Nair Rajesh). Shelley Zieroth Anu Lala-Trindade Anju Bhardwaj MD FACC Nosheen Reza, MD, MS @JJheart_doc Harriette Van Spall, MD MPH 🇨🇦 Dmitry Abramov JK Han MD Nishaki Mehta MD Tahmeed Contractor Kalyanam Shivkumar MD PhD Stavros Stavrakis Sripal Bangalore AHA Science AHAMeetings 10 take-home points #AHA24 #ACCAHAPerioperativeGuidelines ➡️Risk Assessment with DASI, Dont forget Frailty assessment ➡️Low-risk patients going for low-risk NCS- No testing ➡️Cardiac Biomarkers are important in risk stratification + Follow up Monitoring ➡️There is no

TOP LBTs @ #PCRLV 2024⭐ A concise 1 slide summary of all trials 4 those who cant be live at the main arena👀⤵️ Pamela Gatto Ana Paula Tagliari Doc. Dr. Serkan Asil Guillaume Bonnet Mi Chen 陈密 Fiona Kelly Denisa Muraru Tianyuan Alessandro Beneduce Harriet Hurrell Lynne Hinterbuchner Marcio Montenegro Edoardo Zancanaro MD

The training of resident cardiologists needs major reform to meet the needs of patients, say British Cardiovascular Society, BJCA 📊 and 12 other organisations representing CV health professionals in a statement published in Heart today: tinyurl.com/yptuxrpc

A Statement from BCIS President Prof. David Hildick-Smith: "It has taken a long time to get here, but after hard work and strong data from Dawn Adamson, Mamas A. Mamas, Ashan Gunarathne, and others, NHSE England has finally agreed to prioritise STEMI transfer between sites. This

🥸5️⃣ Dapagliflozin reduced the primary outcome: 15.0% vs. 20.1% (hazard ratio 0.72, 95% CI 0.55–0.95, P=0.02).

Impressively educational Medtronic TAVI implanters meeting in sunny London yesterday Medtronic UK

In the randomized, open-label AUREA trial, an OAC strategy for 3 months post-TAVI did not show any benefit over an antiplatelet strategy in preventing cerebral microembolism in patients without an indication for OAC. Patients treated with DAPT showed a lower mean volume of brain

🥸1️⃣1️⃣ Symptomatic intracranial hemorrhage occurred in 1.7% of tirofiban patients and 0% of placebo patients, confirming a higher but still low bleeding risk.

Join our free Structural Training day ; amazing renowned faculty; Hands on simulator experience! Save the date !

POST TAVR Suicide Left Ventricle! Made by CardioNerds

5. Does that sound like a political system that wants to do the best for the NHS? Or for you and your families? I am sure that there will be many keyboard warriors that will post inane responses. But when it is your child that is sick or you having a heart attack or your

Good luck to all the doctors in England- who are rotating to the new job. Specially to the new house officers (F1 Drs).👍😀

Finished William Hayes-Wood book. His analysis is basically correct (meaning I agree with him 😉). It is a very short book and non-academic - just on 100 words. So a few absolutely key things are missed out: 1. The Death of the Firm Partly a byproduct of EWTD, but also a 1/

41 years ago today, Prof Sir Alec Jeffreys made history at Leicester with the discovery of DNA fingerprinting. 🧬A breakthrough that changed science and justice worldwide. Watch ITV’s dramatisation - Code of a Killer: itv.com/watch/code-of-… #CitizensOfChange #DNA41 #MadeAtUni